Crescent Grove Advisors’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-17,880
Closed -$381K – 278
2023
Q2
$381K Hold
17,880
– – 0.04% 206
2023
Q1
$366K Hold
17,880
– – 0.04% 210
2022
Q4
$341K Hold
17,880
– – 0.04% 216
2022
Q3
$300K Hold
17,880
– – 0.03% 209
2022
Q2
$289K Sell
17,880
-464
-3% -$8.07K 0.03% 210
2022
Q1
$346K Buy
18,344
+464
+3% +$8.98K 0.03% 212
2021
Q4
$392K Hold
17,880
– – 0.04% 196
2021
Q3
$328K Hold
17,880
– – 0.03% 193
2021
Q2
$306K Buy
+17,880
New +$302K 0.03% 191

Other funds holding APH

Crescent Grove Advisors's APH Position: Q3 2023 in Review

Crescent Grove Advisors sold out of Amphenol (APH) in Q3 2023, closing a stake of 17,880 shares — an estimated $381K sold.

Crescent Grove Advisors first reported a position in APH in Q2 2021 and held it in 9 quarters. The position peaked at $392K in Q4 2021. 1,008 funds tracked by Wall St. Rank hold APH as of Q3 2023.

  • Crescent Grove Advisors reported no remaining Amphenol position as of Q3 2023 after selling out during the quarter.
  • Crescent Grove Advisors sold 17,880 Amphenol shares in Q3 2023, an estimated $381K.
  • Crescent Grove Advisors first reported a position in Amphenol in Q2 2021 and held it in 9 quarters.
  • Crescent Grove Advisors's Amphenol position peaked at $392K in Q4 2021.
  • 1,008 funds tracked by Wall St. Rank held Amphenol as of Q3 2023.

Based on Crescent Grove Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.